MANKIND:NSE
Mankind Pharma Ltd
₹2,253.20
arrow_downward
-0.98%(-22.30) 1D
Oct 19, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MANKIND...
Open
₹2,264.10
High
₹2,348.50
Low
₹2,246.00
Mkt. cap
926.27B
Avg. vol.
519.08K
Volume
1.23M
P/E ratio
45.59
52-wk high
₹2,642.00
52-wk low
₹1,909.70
EPS
₹49.42
No. of employees
20K
Open
₹2,264.10
High
₹2,348.50
Low
₹2,246.00
Mkt. cap
926.27B
Avg. vol.
519.08K
Volume
1.23M
P/E ratio
45.59
52-wk high
₹2,642.00
52-wk low
₹1,909.70
EPS
₹49.42
No. of employees
20K
News stories
From web sources and news partners
TradingView
·
45 minutes ago
S&P 500, Dow Gain As Earnings Season Sets In, While SpaceX Aids Nasdaq After-Hours — SPCX, BA, MMM, NFLX, QCOM In Focus
Traders Union
·
1 hour ago
George Noble: Energy sector to account for 20% of S&P 500 shareholder payouts
www.tokenpost.com
·
1 hour ago
Dow Gains 0.39% as Nasdaq Falls 1.04% in Oct. 20 Intraday Trade
Yahoo Finance
·
7 hours ago
Alnylam (ALNY): Can the RNAi Franchise Get it an Entry into the S&P 500 Index?
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees20.5K
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitemankindpharma.com